We are live on ! Find out more
LRMR icon

Larimar Therapeutics
LRMR

93 hedge funds and large institutions have $880M invested in Larimar Therapeutics in 2015 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 9

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

83% more capital invested

Capital invested by funds: $481M → $880M (+$398M)

60% more funds holding

Funds holding: 58 → 93 (+35)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
93
Holders Change
+35
Holders Change %
+60.34%
% of All Funds
2.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
44
Increased
32
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCMI
Foresite Capital Management II
California
+$119M
2
DM
Deerfield Management
New York
+$41.5M
3
JHIU
Janus Henderson Investors US
Colorado
+$31.2M
4
Jennison Associates
Jennison Associates
New York
+$26.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.1M

Top Sellers

1
TRV
Third Rock Ventures
Massachusetts
-$55.4M
2
PA
Perceptive Advisors
New York
-$8.58M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.81M
4
SFM
Sphera Funds Management
Israel
-$2.22M
5
Principal Financial Group
Principal Financial Group
Iowa
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
51
TFS Capital
Pennsylvania
$967K +$966K +2,035 New
LCG
52
Lisanti Capital Growth
New York
$939K -$1.3M -2,731 -58%
EI
53
EAM Investors
California
$921K +$920K +1,938 New
ProShare Advisors
54
ProShare Advisors
Maryland
$895K +$241K +507 +37%
Goldman Sachs
55
Goldman Sachs
New York
$888K -$1.49M -3,146 -63%
Deutsche Bank
56
Deutsche Bank
Germany
$875K -$837K -1,764 -49%
RFC
57
Russell Frank Company
Washington
$798K +$798K +1,680 New
Two Sigma Investments
58
Two Sigma Investments
New York
$780K +$779K +1,641 New
Tudor Investment Corp
59
Tudor Investment Corp
Connecticut
$652K +$651K +1,371 New
FAM
60
Fred Alger Management
New York
$604K +$603K +1,271 New
Swiss National Bank
61
Swiss National Bank
Switzerland
$602K +$332K +700 +123%
JRP
62
Jasper Ridge Partners
California
$596K +$595K +1,254 New
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$573K +$67.4K +142 +13%
NFA
64
Nationwide Fund Advisors
Ohio
$551K -$125K -264 -19%
TCM
65
Tekla Capital Management
Massachusetts
$527K -$526K -1,109 -50%
AA
66
ALPS Advisors
Colorado
$515K +$515K +1,084 New
DekaBank Deutsche Girozentrale
67
DekaBank Deutsche Girozentrale
Germany
$487K +$487K +1,025 New
Charles Schwab
68
Charles Schwab
California
$436K +$99.2K +209 +30%
TA
69
Teachers Advisors
New York
$361K +$106K +223 +42%
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
$331K +$330K +696 New
AllianceBernstein
71
AllianceBernstein
Tennessee
$321K +$320K +675 New
Morgan Stanley
72
Morgan Stanley
New York
$288K +$241K +507 +512%
COPPSERS
73
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$247K -$561K -1,182 -69%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$227K +$227K +478 New
Two Sigma Advisers
75
Two Sigma Advisers
New York
$218K +$217K +458 New
1 2
3
4 5

LRMR Hedge Fund Activity: Q1 2015 in Review

93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q1 2015, worth a combined $880M — up 83% from $481M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new LRMR positions and 9 closed out — a net gain of 35 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Foresite Capital Management II, adding an estimated $119M. The largest seller was Third Rock Ventures, cutting an estimated $55.4M.

  • 93 institutional investors held Larimar Therapeutics (LRMR) as of Q1 2015, up from 58 in Q4 2014.
  • Funds reported $880M of Larimar Therapeutics stock for Q1 2015, up 83% quarter-over-quarter.
  • 44 funds opened new Larimar Therapeutics positions in Q1 2015 and 9 closed out, a net change of +35 holders.
  • The largest Larimar Therapeutics buyer in Q1 2015 was Foresite Capital Management II, an estimated $119M added.
  • The largest Larimar Therapeutics seller in Q1 2015 was Third Rock Ventures, an estimated $55.4M sold.

Based on aggregated 13F filings for Q1 2015.